{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:18:53Z","timestamp":1786997933765,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.vaccine.2009.12.001","type":"journal-article","created":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T09:02:48Z","timestamp":1261040568000},"page":"1824-1831","source":"Crossref","is-referenced-by-count":55,"title":["Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: Effects of host background and route of immunization"],"prefix":"10.1016","volume":"28","author":[{"given":"J. Wayne","family":"Conlan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Golovliov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Zingmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra C.F.","family":"Oyston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangxue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert V.","family":"House","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Sj\u00f6stedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2009.12.001_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1409.009","article-title":"Tularemia: History, epidemiology, pathogen physiology and clinical manifestations","volume":"1105","author":"Sjostedt","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2009.12.001_bib2","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1001\/jama.285.21.2763","article-title":"Tularemia as a biological weapon: medical and public health management","volume":"285","author":"Dennis","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2009.12.001_bib3","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1001\/archinte.1961.03620050055006","article-title":"Tularemia vaccine study. I. Intracutaneous challenge","volume":"107","author":"Saslaw","year":"1961","journal-title":"Arch Int Med"},{"key":"10.1016\/j.vaccine.2009.12.001_bib4","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/archinte.1961.03620050068007","article-title":"Tularemia vaccine study II. Respiratory challenge","volume":"107","author":"Saslaw","year":"1961","journal-title":"Arch Int Med"},{"key":"10.1016\/j.vaccine.2009.12.001_bib5","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1128\/MMBR.30.3.532-538.1966","article-title":"Aerogenic immunization of man with live tularemia vaccine","volume":"30","author":"Hornick","year":"1966","journal-title":"Bacteriol Rev"},{"key":"10.1016\/j.vaccine.2009.12.001_bib6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1128\/MMBR.25.3.262-267.1961","article-title":"Aerosol infection of man with Pasteurella tularensis","volume":"25","author":"McCrumb","year":"1961","journal-title":"Bacteriol Rev"},{"key":"10.1016\/j.vaccine.2009.12.001_bib7","doi-asserted-by":"crossref","first-page":"3690","DOI":"10.1016\/S0264-410X(03)00386-4","article-title":"Tularemia in BALB\/c and C57BL\/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen; protection varies depending on pathogen virulence, route of exposure, and host genetic background","volume":"21","author":"Chen","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.12.001_bib8","doi-asserted-by":"crossref","first-page":"2116","DOI":"10.1016\/j.vaccine.2003.12.003","article-title":"Susceptibility of various mouse strains to systemically or aerosol- initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen","volume":"22","author":"Shen","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.12.001_bib9","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1128\/IAI.73.5.2644-2654.2005","article-title":"Intransal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A","volume":"73","author":"Wu","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.12.001_bib10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1196\/annals.1409.003","article-title":"Animal models of Francisella tularensis infection","volume":"1105","author":"Lyons","year":"2007","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vaccine.2009.12.001_bib11","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3181\/00379727-108-27049","article-title":"Aerogenic immunization of the monkey and guinea pig with live tularemia vaccine","volume":"108","author":"Eigelsbach","year":"1961","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.vaccine.2009.12.001_bib12","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.vaccine.2004.10.034","article-title":"Aerosol-, but not intradermal- immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an \u03b1\u03b2 T cell- and interferon gamma- dependent mechanism","volume":"23","author":"Conlan","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.12.001_bib13","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1016\/j.vaccine.2007.02.014","article-title":"Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis","volume":"25","author":"KuoLee","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.12.001_bib14","doi-asserted-by":"crossref","first-page":"8345","DOI":"10.1128\/IAI.73.12.8345-8352.2005","article-title":"A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58kDa protein is attenuated for virulence and an effective live vaccine","volume":"73","author":"Twine","year":"2005","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.12.001_bib15","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1128\/IAI.66.5.2099-2106.1998","article-title":"Identification of Salmonella typhimurium genes required for colonization of the chicken alimentary tract and for virulence in newly hatched chicks","volume":"66","author":"Turner","year":"1998","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.12.001_bib16","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1128\/JB.186.4.1165-1174.2004","article-title":"clpB a novel member of the Listeria monocytogenes ctsR regulon is involved in virulence but not in general stress tolerance","volume":"186","author":"Chastanet","year":"2004","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2009.12.001_bib17","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.1128\/IAI.01865-06","article-title":"Genome-wide identification of Francisella tularensis virulence determinants","volume":"75","author":"Su","year":"2007","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.12.001_bib18","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/j.1365-2958.2008.06139.x","article-title":"The heat-shock protein clpB of Francisella tularensis is involved in stress tolerance and is required for multiplication in target organs of infected mice","volume":"67","author":"Meibom","year":"2008","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2009.12.001_bib19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1574-6968.2002.tb11369.x","article-title":"The identification of five genetic loci of Francisella novicida associated with intracellular growth","volume":"215","author":"Gray","year":"2002","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2009.12.001_bib20","doi-asserted-by":"crossref","first-page":"5095","DOI":"10.1128\/IAI.00598-06","article-title":"Attenuated Francisella novicida transposon mutants protect mice against wild-type challenge","volume":"74","author":"Tempel","year":"2006","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.12.001_bib21","doi-asserted-by":"crossref","first-page":"6037","DOI":"10.1073\/pnas.0609675104","article-title":"In vivo negative selection screen identifies genes required for Francisella virulence","volume":"104","author":"Weiss","year":"2007","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.vaccine.2009.12.001_bib22","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/ng1499","article-title":"The complete genome sequence of Francisella tularensis, the causative agent of tularemia","volume":"37","author":"Larsson","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.vaccine.2009.12.001_bib23","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0378-1097(03)00313-6","article-title":"A method for allelic replacement in Francisella tularensis","volume":"222","author":"Golovliov","year":"2002","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.vaccine.2009.12.001_bib24","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1128\/IAI.00374-08","article-title":"Native outer membrane proteins protect mice against pulmonary challenge with virulent type A Francisella tularensis","volume":"76","author":"Huntley","year":"2008","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.12.001_bib25","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1128\/CVI.00405-08","article-title":"Oral live vaccine-strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A","volume":"16","author":"Ray","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2009.12.001_bib26","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1016\/j.molimm.2008.01.022","article-title":"Molecular immunology of experimental primary tularemia in mice infected by respiratory or intradermal routes with type A Francisella tularensis","volume":"45","author":"Conlan","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2009.12.001_bib27","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/j.vaccine.2008.01.005","article-title":"An improved Francsiella tularensis live vaccine strain (LVS) is well tolerated and highly immunogenic when administered to rabbits in escalating doses using various immunization routes","volume":"26","author":"Pasetti","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.12.001_bib28","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.vaccine.2005.08.045","article-title":"Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children","volume":"24","author":"Wong-Chew","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.12.001_bib29","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1128\/AAC.00517-07","article-title":"Comparative immunogenicities of frozen and refrigerated forulations of live attenuated influenza vaccine in healthy subjects","volume":"51","author":"Block","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2009.12.001_bib30","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1016\/j.vaccine.2005.04.002","article-title":"Comparative pre-clinical and clinical experience with oral polio vaccine produced on MRC-5 cells or on primary monkey kidney cells","volume":"23","author":"Prikazsky","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.12.001_bib31","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1086\/431605","article-title":"The novel oral typhoid vaccine M01ZH09 is well tolerated and highly immunogenic in 2 vaccine presentations","volume":"192","author":"Kirkpatrick","year":"2005","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2009.12.001_bib32","first-page":"11","article-title":"Oral tularemia vaccine in man","volume":"6","author":"Hornick","year":"1966","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2009.12.001_bib33","doi-asserted-by":"crossref","first-page":"2922","DOI":"10.1128\/IAI.59.9.2922-2928.1991","article-title":"Live vaccine strain of Francisella tularensis: infection and immunity in mice","volume":"59","author":"Fortier","year":"1991","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.12.001_bib34","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1006\/mpat.2001.0489","article-title":"Different host defences are required to protect mice from primary systemic vs pulmonary infection with the facultative intracellular bacterial pathogen, Francisella tularensis LVS","volume":"32","author":"Conlan","year":"2002","journal-title":"Microb Pathog"},{"key":"10.1016\/j.vaccine.2009.12.001_bib35","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1046\/j.1365-2567.1999.00663.x","article-title":"Genetically susceptible mice remain proportionally more susceptible to tuberculosis after vaccination","volume":"96","author":"Medina","year":"1999","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2009.12.001_bib36","first-page":"829","article-title":"Cell-mediated resistance to aerogenic infection of the lung","volume":"104","author":"Truitt","year":"1971","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.vaccine.2009.12.001_bib37","first-page":"393","article-title":"Salmonella vaccines for use in humans: present and future perspectives","volume":"26","author":"Garmory","year":"2002","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2009.12.001_bib38","first-page":"45","article-title":"Aromatic-dependent Salmonella as anti-bacterial vaccines and as presenters of heterologous antigens or of DNA encoding them","volume":"83","author":"Stocker","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2009.12.001_bib39","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/nrmicro1662","article-title":"Clinical trials of Shigella vaccines: two steps forward and one step back on a long, hard road","volume":"5","author":"Levine","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.vaccine.2009.12.001_bib40","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1128\/IAI.65.2.452-456.1997","article-title":"Safety of live oral Salmonella typhi vaccine strains with deletions in htrA and aroC aroD and immune response in humans","volume":"65","author":"Tacket","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2009.12.001_bib41","doi-asserted-by":"crossref","first-page":"3457","DOI":"10.1128\/IAI.70.7.3457-3467.2002","article-title":"Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers","volume":"70","author":"Hindle","year":"2002","journal-title":"Infect Immun"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09019045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X09019045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,24]],"date-time":"2020-05-24T05:08:42Z","timestamp":1590296922000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X09019045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S0264410X09019045"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2009.12.001","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}